| __timestamp | AstraZeneca PLC | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 13324000000 | 660772000 |
| Thursday, January 1, 2015 | 11451000000 | 736435000 |
| Friday, January 1, 2016 | 9739000000 | 775266000 |
| Sunday, January 1, 2017 | 10543000000 | 860348000 |
| Monday, January 1, 2018 | 10362000000 | 814775000 |
| Tuesday, January 1, 2019 | 11848000000 | 942821000 |
| Wednesday, January 1, 2020 | 11693000000 | 985616000 |
| Friday, January 1, 2021 | 15680000000 | 1061508000 |
| Saturday, January 1, 2022 | 18955000000 | 1190423000 |
| Sunday, January 1, 2023 | 18025000000 | 1254234000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding spending patterns is crucial. From 2014 to 2023, AstraZeneca PLC and Grifols, S.A. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. AstraZeneca's SG&A expenses have surged by approximately 35% over this period, peaking in 2022. This reflects their aggressive market expansion and strategic investments. In contrast, Grifols has maintained a steadier growth, with a 90% increase in SG&A expenses, indicating a more conservative approach. Notably, AstraZeneca's expenses in 2023 were nearly 14 times higher than Grifols, highlighting their differing scales and strategies. These insights provide a window into how these pharmaceutical giants allocate resources to maintain competitive edges in a dynamic market.
Comparing SG&A Expenses: AbbVie Inc. vs Grifols, S.A. Trends and Insights
Comparing SG&A Expenses: Merck & Co., Inc. vs AstraZeneca PLC Trends and Insights
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Bristol-Myers Squibb Company
AstraZeneca PLC or Bio-Techne Corporation: Who Manages SG&A Costs Better?
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: AstraZeneca PLC vs PTC Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: AstraZeneca PLC vs ImmunityBio, Inc. Trends and Insights
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Grifols, S.A.
BioMarin Pharmaceutical Inc. vs Grifols, S.A.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Grifols, S.A.
Breaking Down SG&A Expenses: Grifols, S.A. vs TG Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Grifols, S.A. or Iovance Biotherapeutics, Inc.